Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Accenture PLC Cl A Stock Climbs 3.2%, Outperforms Peers

Accenture PLC Cl A Stock Climbs 3.2%, Outperforms Peers

Dow JonesDow Jones2026/10/19 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Accenture PLC Cl A rose 3.2% to $236.93 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.4% to 7,690.73 and the Dow Jones Industrial Average falling 0.1% to 51,966.03.

This was the stock's fourth consecutive day of gains.

Accenture PLC Cl A closed 18.6% short of its 52-week high of $291.09, which the company reached on January 14th.

The stock outperformed some of its peers, as International Business Machines Corp. rose 1.8% to $236.39, Automatic Data Processing Inc. fell 0.7% to $286.93, and Cognizant Technology Solutions Corp. rose 1.11% to $66.76.

Trading volume totaled 6.9 million, compared to the 50-day average of 6.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 19, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

TS Lombard scenario analysis: An AI bubble burst could trigger a 30% plunge in the S&P 500, wiping out 20 trillion dollars in market value—but don't rush to short!

Dario Perkins from TS Lombard predicted in a scenario analysis released on Thursday that if AI capital expenditure collapses, approximately $20 trillions in U.S. stock market value could evaporate, triggering credit losses of $125 billions to $190 billions.

智通财经•2026/10/23 00:56

Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline

Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.

智通财经•2026/10/23 00:37

Japan's core CPI rose 2.1% year-on-year in September, surpassing the central bank's 2% target for the first time in nine months! Broadening inflation strengthens expectations of a near-term rate hike.

Data released on Friday showed that Japan’s core Consumer Price Index (CPI) rose by 2.1% year-on-year in September, exceeding the Bank of Japan’s 2% inflation target for the first time in nine months. This indicates that price pressures are spreading and reinforces market expectations of an interest rate hike in the near future.

智通财经•2026/10/23 00:26
Japan's core CPI rose 2.1% year-on-year in September, surpassing the central bank's 2% target for the first time in nine months! Broadening inflation strengthens expectations of a near-term rate hike.